KALV 8-K 2026-01-08

KalVista Pharmaceuticals, Inc. (KALV) 8-K dated 2026-01-08 — accession 0001193125-26-007801. This URL is the filing, not the KALV hub.

KalVista Pharmaceuticals, Inc. (KALV) is a biotechnology company listed on NASDAQ.

KalVista Pharmaceuticals, Inc. filed a 8-K on 2026-01-08. Accession 0001193125-26-007801.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KALV revenue for 2025-12-31 was $49.1M. Net income was -$109.5M. Revenue was down 1.8% from 2024-04-30 to 2025-12-31. KALV currently screens at market cap $1.44B.

Not investment advice. The KALV SEC hub lists recent forms. The stock page is the research view.